Several less well-known disorders share some characteristics with CML. These rare CML-like disorders are distinct entities that require specific diagnostic and treatment considerations. Atypical CML, ...

Chronic myeloid leukemia (CML) is a type of blood cancer that people may also refer to as chronic myelogenous leukemia. Doctors diagnose the stage of CML based on the number of leukemia cells, or ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. The diagnosis has become much, much easier.

Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis. The initial discussions with health care ...

Chronic myeloid leukemia (CML) is a blood and bone marrow cancer. It results in the production of too many immature blood cells, called myeloblasts. Doctors can classify CML into 3 phases using lab ...

Diagnosing chronic myeloid leukemia (CML) involves blood and bone marrow tests, like a bone marrow biopsy. A biopsy shows if you have cancer. It will also give details about the type and subtype you ...

An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia. Receiving a diagnosis of chronic myeloid leukemia (CML) can be ...

CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before the advent ...

A single institution retrospective review of characteristics and outcomes of patients requiring chronic dose reduction of TKIs given as front-line therapy for chronic phase CML. This is an ASCO ...

NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (PRPO) leveraged its proprietary HemeScreen technology as part of the diagnostic process to ...

Hyper-CVAD plus nelarabine in the treatment of newly diagnosed patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LL). This is an ASCO Meeting Abstract from the 2011 ASCO ...